Syndecan-1 enhances proliferation, migration and metastasis of HT-1080 cells in cooperation with Syndecan-2

PLoS ONE

Volumn 7, Issue 6, 2012, Pages

  Péterfia, Bálint ^a   Füle, Tibor ^a   Baghy, Kornélia ^a   Szabadkai, Krisztina ^a   Fullár, Alexandra ^a   Dobos, Katalin ^a   Zong, Fang ^b   Dobra, Katalin ^b   Hollósi, Péter ^a   Jeney, András ^a   Paku, Sándor ^a   Kovalszky, Ilona ^a  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b KAROLINSKA INSTITUTE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

SOMATOMEDIN C; SYNDECAN 1; SYNDECAN 2; TRANSCRIPTION FACTOR ETS 1;

AMINO ACID COMPOSITION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER GROWTH; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CHEMOTAXIS; CONTROLLED STUDY; FEMALE; FIBROSARCOMA; GENE ACTIVATION; GENE ACTIVITY; GENE EXPRESSION REGULATION; GENE OVEREXPRESSION; GENE SILENCING; GROWTH RATE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LUNG METASTASIS; MOUSE; NONHUMAN; TUMOR PROMOTION;

CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; HUMANS; PROTO-ONCOGENE PROTEIN C-ETS-1; RECEPTOR, IGF TYPE 1; SYNDECAN-1; SYNDECAN-2;

EID: 84862746844     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0039474     Document Type: Article

References (49)

1. Couchman JR, (2010) Transmembrane signaling proteoglycans. Annu Rev Cell Dev Biol 26: 89-114.
2. Teng YH, Aquino RS, Park PW, (2011) Molecular functions of syndecan-1 in disease. Matrix Biol.
3. Beauvais DM, Rapraeger AC, (2004) Syndecans in tumor cell adhesion and signaling. Reprod Biol Endocrinol 2: 3.
4. Whiteford JR, Couchman JR, (2006) A conserved NXIP motif is required for cell adhesion properties of the syndecan-4 ectodomain. J Biol Chem 281: 32156-32163.
5. Whiteford JR, Xian X, Chaussade C, Vanhaesebroeck B, Nourshargh S, et al. (2011) Syndecan-2 is a novel ligand for the protein tyrosine phosphatase receptor CD148. Mol Biol Cell 22: 3609-3624.
6. Choi Y, Chung H, Jung H, Couchman JR, Oh ES, (2011) Syndecans as cell surface receptors: Unique structure equates with functional diversity. Matrix Biol 30: 93-99.
7. Carey DJ, (1997) Syndecans: multifunctional cell-surface co-receptors. Biochem J 327 (Pt 1): 1-16.
8. Manon-Jensen T, Itoh Y, Couchman JR, (2010) Proteoglycans in health and disease: the multiple roles of syndecan shedding. FEBS J 277: 3876-3889.
9. Hinkes MT, Goldberger OA, Neumann PE, Kokenyesi R, Bernfield M, (1993) Organization and promoter activity of the mouse syndecan-1 gene. J Biol Chem 268: 11440-11448.
10. David G, Bai XM, Van der Schueren B, Marynen P, Cassiman JJ, et al. (1993) Spatial and temporal changes in the expression of fibroglycan (syndecan-2) during mouse embryonic development. Development 119: 841-854.
11. Vainio S, Jalkanen M, Thesleff I, (1989) Syndecan and tenascin expression is induced by epithelial-mesenchymal interactions in embryonic tooth mesenchyme. J Cell Biol 108: 1945-1953.
12. Bai XM, Van der Schueren B, Cassiman JJ, Van den Berghe H, David G, (1994) Differential expression of multiple cell-surface heparan sulfate proteoglycans during embryonic tooth development. J Histochem Cytochem 42: 1043-1054.
13. Solursh M, Reiter RS, Jensen KL, Kato M, Bernfield M, (1990) Transient expression of a cell surface heparan sulfate proteoglycan (syndecan) during limb development. Dev Biol 140: 83-92.
14. Sanderson RD, Lalor P, Bernfield M, (1989) B lymphocytes express and lose syndecan at specific stages of differentiation. Cell Regul 1: 27-35.
15. Lories V, Cassiman JJ, Van den Berghe H, David G, (1992) Differential expression of cell surface heparan sulfate proteoglycans in human mammary epithelial cells and lung fibroblasts. J Biol Chem 267: 1116-1122.
16. Essner JJ, Chen E, Ekker SC, (2006) Syndecan-2. Int J Biochem Cell Biol 38: 152-156.
17. Orosz Z, Kopper L, (2001) Syndecan-1 expression in different soft tissue tumours. Anticancer Res 21: 733-737.
18. Kumar-Singh S, Jacobs W, Dhaene K, Weyn B, Bogers J, et al. (1998) Syndecan-1 expression in malignant mesothelioma: correlation with cell differentiation, WT1 expression, and clinical outcome. J Pathol 186: 300-305.
19. Chu PG, Arber DA, Weiss LM, (2003) Expression of T/NK-cell and plasma cell antigens in nonhematopoietic epithelioid neoplasms. An immunohistochemical study of 447 cases. Am J Clin Pathol 120: 64-70.
20. Saqi A, Yun SS, Yu GH, Alexis D, Taub RN, et al. (2005) Utility of CD138 (syndecan-1) in distinguishing carcinomas from mesotheliomas. Diagn Cytopathol 33: 65-70.
21. Dobra K, Nurminen M, Hjerpe A, (2003) Growth factors regulate the expression profile of their syndecan co-receptors and the differentiation of mesothelioma cells. Anticancer Res 23: 2435-2444.
22. Park H, Han I, Kwon HJ, Oh ES, (2005) Focal adhesion kinase regulates syndecan-2-mediated tumorigenic activity of HT1080 fibrosarcoma cells. Cancer Res 65: 9899-9905.
23. Orosco A, Fromigue O, Bazille C, Entz-Werle N, Levillain P, et al. (2007) Syndecan-2 affects the basal and chemotherapy-induced apoptosis in osteosarcoma. Cancer Res 67: 3708-3715.
24. Modrowski D, Orosco A, Thevenard J, Fromigue O, Marie PJ, (2005) Syndecan-2 overexpression induces osteosarcoma cell apoptosis: Implication of syndecan-2 cytoplasmic domain and JNK signaling. Bone 37: 180-189.
25. Theocharis AD, Skandalis SS, Tzanakakis GN, Karamanos NK, (2010) Proteoglycans in health and disease: novel roles for proteoglycans in malignancy and their pharmacological targeting. FEBS J 277: 3904-3923.
26. Peterfia B, Hollosi P, Szilak L, Timar F, Paku S, et al. (2006) [Role of syndecan-1 proteoglycan in the invasiveness of HT-1080 fibrosarcoma]. Magy Onkol pp. 115-120.
27. Longley RL, Woods A, Fleetwood A, Cowling GJ, Gallagher JT, et al. (1999) Control of morphology, cytoskeleton and migration by syndecan-4. J Cell Sci 112 (Pt 20): 3421-3431.
28. Uphoff CC, Drexler HG, (2002) Detection of mycoplasma in leukemia-lymphoma cell lines using polymerase chain reaction. Leukemia 16: 289-293.
29. Hanyu A, Kojima K, Hatake K, Nomura K, Murayama H, et al. (2009) Functional in vivo optical imaging of tumor angiogenesis, growth, and metastasis prevented by administration of anti-human VEGF antibody in xenograft model of human fibrosarcoma HT1080 cells. Cancer Sci 100: 2085-2092.
30. Feldman JP, Goldwasser R, Mark S, Schwartz J, Orion I, (2009) A Mathematical Model for Tumor Volume Evaluation using Two-Dimensions. J Appl Quant Methods: Association for Development through Science and Education pp. 455-462.
31. Bradford MM, (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254.
32. Burbach BJ, Friedl A, Mundhenke C, Rapraeger AC, (2003) Syndecan-1 accumulates in lysosomes of poorly differentiated breast carcinoma cells. Matrix Biol 22: 163-177.
33. Leivonen M, Lundin J, Nordling S, von Boguslawski K, Haglund C, (2004) Prognostic value of syndecan-1 expression in breast cancer. Oncology 67: 11-18.
34. Juuti A, Nordling S, Lundin J, Louhimo J, Haglund C, (2005) Syndecan-1 expression-a novel prognostic marker in pancreatic cancer. Oncology 68: 97-106.
35. Wiksten JP, Lundin J, Nordling S, Lundin M, Kokkola A, et al. (2001) Epithelial and stromal syndecan-1 expression as predictor of outcome in patients with gastric cancer. Int J Cancer 95: 1-6.
36. Davies EJ, Blackhall FH, Shanks JH, David G, McGown AT, et al. (2004) Distribution and clinical significance of heparan sulfate proteoglycans in ovarian cancer. Clin Cancer Res 10: 5178-5186.
37. Mathe M, Suba Z, Nemeth Z, Tatrai P, Fule T, et al. (2006) Stromal syndecan-1 expression is an adverse prognostic factor in oral carcinomas. Oral Oncol 42: 493-500.
38. Lendorf ME, Manon-Jensen T, Kronqvist P, Multhaupt HA, Couchman JR, (2011) Syndecan-1 and syndecan-4 are independent indicators in breast carcinoma. J Histochem Cytochem 59: 615-629.
39. Endo K, Takino T, Miyamori H, Kinsen H, Yoshizaki T, et al. (2003) Cleavage of syndecan-1 by membrane type matrix metalloproteinase-1 stimulates cell migration. J Biol Chem 278: 40764-40770.
40. Nikolova V, Koo CY, Ibrahim SA, Wang Z, Spillmann D, et al. (2009) Differential roles for membrane-bound and soluble syndecan-1 (CD138) in breast cancer progression. Carcinogenesis 30: 397-407.
41. Kusano Y, Yoshitomi Y, Munesue S, Okayama M, Oguri K, (2004) Cooperation of syndecan-2 and syndecan-4 among cell surface heparan sulfate proteoglycans in the actin cytoskeletal organization of Lewis lung carcinoma cells. J Biochem 135: 129-137.
42. Averbeck M, Gebhardt C, Anderegg U, Termeer C, Sleeman JP, et al. (2007) Switch in syndecan-1 and syndecan-4 expression controls maturation associated dendritic cell motility. Exp Dermatol 16: 580-589.
43. Zong F, Fthenou E, Castro J, Peterfia B, Kovalszky I, et al. (2009) Effect of syndecan-1 overexpression on mesenchymal tumour cell proliferation with focus on different functional domains. Cell Prolif.
44. Lents NH, Gorges LL, Baldassare JJ, (2006) Reverse mutational analysis reveals threonine-373 as a potentially sufficient phosphorylation site for inactivation of the retinoblastoma tumor suppressor protein (pRB). Cell Cycle 5: 1699-1707.
45. Hoshino R, Tanimura S, Watanabe K, Kataoka T, Kohno M, (2001) Blockade of the extracellular signal-regulated kinase pathway induces marked G1 cell cycle arrest and apoptosis in tumor cells in which the pathway is constitutively activated: up-regulation of p27(Kip1). J Biol Chem 276: 2686-2692.
46. Zong F, Fthenou E, Mundt F, Szatmari T, Kovalszky I, et al. (2011) Specific syndecan-1 domains regulate mesenchymal tumor cell adhesion, motility and migration. PLoS One 6: e14816.
47. Beauvais DM, Rapraeger AC, (2010) Syndecan-1 couples the insulin-like growth factor-1 receptor to inside-out integrin activation. J Cell Sci 123: 3796-3807.
48. Hahne JC, Kummer S, Heukamp LC, Fuchs T, Gun M, et al. (2009) Regulation of protein tyrosine kinases in tumour cells by the transcription factor Ets-1. Int J Oncol 35: 989-996.
49. Hahne JC, Okuducu AF, Sahin A, Fafeur V, Kiriakidis S, et al. (2008) The transcription factor ETS-1: its role in tumour development and strategies for its inhibition. Mini Rev Med Chem 8: 1095-1105.